Alexion Pharmaceuticals - 23 Year Stock Price History | ALXN

Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Alexion Pharmaceuticals as of February 22, 2019 is 129.73.
Alexion Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 117.8611 98.0500 129.8400 98.0500 129.7300 33.25%
2018 120.0025 124.0500 139.0100 93.9400 97.3600 -18.59%
2017 125.7262 122.6300 146.6900 97.7000 119.5900 -2.26%
2016 134.8574 184.6800 184.9000 110.0100 122.3500 -35.86%
2015 177.6471 186.6000 207.8400 145.6000 190.7500 3.09%
2014 166.7312 133.4400 200.7900 129.8200 185.0300 39.24%
2013 104.9874 100.0500 132.9100 83.3900 132.8840 41.76%
2012 94.2987 70.5700 118.1500 70.2900 93.7400 31.10%
2011 53.8780 40.6650 71.5500 40.6650 71.5000 77.53%
2010 29.1347 24.1250 41.1700 22.7500 40.2750 64.99%
2009 20.1819 18.0650 24.4100 15.8250 24.4100 34.90%
2008 18.1343 18.8775 23.7525 12.7425 18.0950 -3.53%
2007 13.6236 10.1525 19.9500 8.9425 18.7575 85.76%
2006 8.7138 5.0725 11.3500 5.0150 10.0975 99.46%
2005 6.0305 6.0925 7.4975 4.6550 5.0625 -19.64%
2004 4.9553 4.3125 6.3750 3.3925 6.3000 48.15%
2003 3.8358 3.6250 5.2300 2.5850 4.2525 20.47%
2002 4.0792 5.7750 6.5650 2.3950 3.5300 -42.23%
2001 6.3246 15.3900 18.6875 3.7375 6.1100 -62.37%
2000 17.8134 7.3750 29.0750 6.9375 16.2350 115.53%
1999 3.2124 3.1250 7.8450 2.1095 7.5325 125.19%
1998 2.7282 2.9700 3.7500 1.5000 3.3450 7.04%
1997 2.7061 2.1875 3.8450 2.0313 3.1250 43.84%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $29.015B $4.131B
Alexion Pharmaceuticals, Inc. is a global biopharmaceutical company focused on serving patients and families affected by rare diseases through the innovation, development and commercialization of life-changing therapies. Alexion is the global leader in complement inhibition and has developed and commercializes the first and only approved complement inhibitor to treat patients with paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG). In addition, Alexion has two highly innovative enzyme replacement therapies for patients with life-threatening and ultra-rare metabolic disorders, hypophosphatasia (HPP) and lysosomal acid lipase deficiency (LAL-D).
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $116.316B 12.97
Gilead Sciences (GILD) United States $86.647B 10.87
Biogen (BIIB) United States $65.929B 12.77
Celgene (CELG) United States $63.373B 11.74
Vertex Pharmaceuticals (VRTX) United States $48.023B 64.33
Regeneron Pharmaceuticals (REGN) United States $46.170B 21.45
Illumina (ILMN) United States $44.429B 52.84
Incyte (INCY) United States $17.925B 167.48
BioMarin Pharmaceutical (BMRN) United States $16.143B 0.00
Seattle Genetics (SGEN) United States $11.201B 0.00
Exact Sciences (EXAS) United States $10.278B 0.00
Sarepta Therapeutics (SRPT) United States $9.393B 0.00
QIAGEN (QGEN) Netherlands $8.890B 29.07
Alnylam Pharmaceuticals (ALNY) United States $8.262B 0.00
BeiGene (BGNE) Cayman Islands $8.259B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.748B 49.54
Bio-Techne Corp (TECH) United States $7.316B 49.29
Bluebird Bio (BLUE) United States $7.298B 0.00
Moderna (MRNA) United States $6.553B 0.00
Exelixis (EXEL) United States $6.350B 14.85
Amarin (AMRN) Ireland $5.554B 0.00
Alkermes (ALKS) Ireland $5.204B 0.00
Galapagos (GLPG) Belgium $5.177B 0.00
Array BioPharma (ARRY) United States $5.056B 0.00
Guardant Health (GH) United States $4.324B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.034B 0.00
Allogene Therapeutics (ALLO) United States $3.728B 0.00
Horizon Pharma Public (HZNP) Ireland $3.611B 14.85
Blueprint Medicines (BPMC) United States $3.388B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.346B 0.00
Emergent Biosolutions (EBS) United States $3.319B 27.96
Ultragenyx Pharmaceutical (RARE) United States $3.062B 0.00
Genomic Health (GHDX) United States $3.022B 78.93
Ascendis Pharma (ASND) Denmark $2.941B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.937B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.854B 0.00
Immunomedics (IMMU) United States $2.735B 0.00
China Biologic Products (CBPO) China $2.677B 19.06
Global Blood Therapeutics (GBT) United States $2.640B 0.00
Reata Pharmaceuticals (RETA) United States $2.596B 0.00
Repligen (RGEN) United States $2.588B 80.82
Mirati Therapeutics (MRTX) United States $2.585B 0.00
Ligand Pharmaceuticals (LGND) United States $2.527B 18.15
Arena Pharmaceuticals (ARNA) United States $2.464B 0.00
Halozyme Therapeutics (HALO) United States $2.439B 54.42
Myriad Genetics (MYGN) United States $2.343B 23.87
Akcea Therapeutics (AKCA) United States $2.343B 0.00
Amicus Therapeutics (FOLD) United States $2.099B 0.00
Insmed (INSM) United States $2.006B 0.00
Denali Therapeutics (DNLI) United States $1.999B 0.00
Acceleron Pharma (XLRN) United States $1.940B 0.00
Spark Therapeutics (ONCE) United States $1.921B 0.00
Atara Biotherapeutics (ATRA) United States $1.798B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.782B 0.00
Medicines (MDCO) United States $1.765B 0.00
MyoKardia (MYOK) United States $1.757B 0.00
AnaptysBio (ANAB) United States $1.740B 0.00
NeoGenomics (NEO) United States $1.724B 141.92
CRISPR Therapeutics AG (CRSP) Switzerland $1.660B 0.00
REGENXBIO (RGNX) United States $1.657B 22.23
Zai Lab Unsponsored ADR (ZLAB) China $1.637B 0.00
Allakos (ALLK) United States $1.530B 0.00
Innoviva (INVA) United States $1.482B 4.09
Myovant Sciences (MYOV) United Kingdom $1.479B 0.00
UniQure (QURE) Netherlands $1.467B 0.00
ALECTOR INC (ALEC) United States $1.430B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.388B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.380B 0.00
Aimmune Therapeutics (AIMT) United States $1.363B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.342B 0.00
Cambrex (CBM) United States $1.286B 13.87
Clovis Oncology (CLVS) United States $1.278B 0.00
GOSSAMER BIO (GOSS) United States $1.273B 0.00
Lion Biotechnologies (IOVA) United States $1.218B 0.00
Codexis (CDXS) United States $1.178B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.115B 0.00
Audentes Therapeutics (BOLD) United States $1.110B 0.00
WAVE Life Sciences (WVE) Singapore $1.093B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.076B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.072B 43.32
Rubius Therapeutics (RUBY) United States $1.067B 0.00
Puma Biotechnology (PBYI) United States $1.020B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.011B 0.00
Coherus BioSciences (CHRS) United States $0.986B 0.00
Editas Medicine (EDIT) United States $0.983B 0.00
Epizyme (EPZM) United States $0.967B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.959B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.958B 0.00
Fate Therapeutics (FATE) United States $0.926B 0.00
Retrophin (RTRX) United States $0.864B 0.00
Sangamo Therapeutics (SGMO) United States $0.864B 0.00
Athenex (ATNX) United States $0.854B 0.00
Vericel (VCEL) United States $0.840B 0.00
CytomX Therapeutics (CTMX) United States $0.791B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.782B 0.00
Apellis Pharmaceuticals (APLS) United States $0.780B 0.00
InflaRx (IFRX) Germany $0.767B 0.00
Novavax (NVAX) United States $0.766B 0.00
G1 THERAPEUTICS (GTHX) United States $0.752B 0.00
Heska (HSKA) United States $0.751B 61.47
Intra-Cellular Therapies (ITCI) United States $0.733B 0.00
Principia Biopharma (PRNB) United States $0.724B 0.00
ANI Pharmaceuticals (ANIP) United States $0.721B 13.80
Cellectis (CLLS) France $0.715B 0.00
Arvinas (ARVN) United States $0.711B 0.00
Dynavax Technologies (DVAX) United States $0.689B 0.00
Revance Therapeutics (RVNC) United States $0.665B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.654B 0.00
Cara Therapeutics (CARA) United States $0.650B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.641B 0.00
Synthorx (THOR) United States $0.637B 0.00
Twist Bioscience (TWST) United States $0.630B 0.00
Viking Therapeutics (VKTX) United States $0.627B 0.00
Acorda Therapeutics (ACOR) United States $0.623B 8.09
Intellia Therapeutics (NTLA) United States $0.604B 0.00
RA PHARMCTL INC (RARX) United States $0.601B 0.00
UROGEN PHARMA (URGN) Israel $0.573B 0.00
Kura Oncology (KURA) United States $0.572B 0.00
Anika Therapeutics (ANIK) United States $0.569B 23.56
Eidos Therapeutics (EIDX) United States $0.567B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.567B 0.00
Osiris Therapeutics (OSIR) United States $0.554B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.550B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Arcus Biosciences (RCUS) United States $0.516B 0.00
PDL BioPharma (PDLI) United States $0.511B 8.33
DBV Technologies (DBVT) France $0.493B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.492B 0.00
Zymeworks (ZYME) Canada $0.482B 0.00
UNITY Biotechnology (UBX) $0.477B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.476B 0.00
Senesco Technologies (ELOX) United States $0.458B 0.00
Scholar Rock Holding (SRRK) United States $0.455B 0.00
Zealand Pharma (ZEAL) Denmark $0.453B 5.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.445B 0.00
BeyondSpring (BYSI) United States $0.444B 0.00
ObsEva SA (OBSV) Switzerland $0.439B 0.00
Replimune (REPL) United States $0.437B 0.00
Five Prime Therapeutics (FPRX) United States $0.421B 0.00
Kezar Life Sciences (KZR) United States $0.403B 0.00
Cytokineticsorporated (CYTK) United States $0.402B 0.00
Mesoblast (MESO) Australia $0.401B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.398B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.387B 0.00
OSMOTICA PHARM (OSMT) United States $0.375B 0.00
Stemline Therapeutics (STML) United States $0.372B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.371B 0.00
Sinovac Biotech (SVA) China $0.367B 0.00
Kindred Biosciences (KIN) United States $0.364B 0.00
MediciNova (MNOV) United States $0.362B 0.00
AVROBIO (AVRO) United States $0.360B 0.00
Agenus (AGEN) United States $0.359B 0.00
Inovio Pharmaceuticals (INO) United States $0.358B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Gritstone Oncology (GRTS) United States $0.351B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.340B 0.00
Gamida Cell (GMDA) Israel $0.339B 0.00
BioDelivery Sciences (BDSI) United States $0.337B 0.00
Krystal Biotech (KRYS) United States $0.327B 0.00
Urovant Sciences (UROV) United States $0.318B 0.00
Evelo Biosciences (EVLO) United States $0.315B 0.00
Abeona Therapeutics (ABEO) United States $0.314B 0.00
Albireo Pharma (ALBO) United States $0.310B 0.00
Solid Biosciences (SLDB) United States $0.309B 0.00
Cellular Biomedicine (CBMG) United States $0.308B 0.00
Aduro Biotech (ADRO) United States $0.307B 0.00
XBiotech (XBIT) United States $0.306B 0.00
Magenta Therapeutics (MGTA) United States $0.305B 0.00
Intec Pharma (NTEC) Israel $0.293B 0.00
Enochian BioSciences (ENOB) United States $0.291B 0.00
Constellation Pharmaceuticals (CNST) United States $0.288B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.282B 0.00
Kala Pharmaceuticals (KALA) United States $0.280B 0.00
AC Immune SA (ACIU) Switzerland $0.277B 0.00
Geron (GERN) United States $0.276B 0.00
Kadmon Holdings (KDMN) United States $0.273B 0.00
Sorrento Therapeutics (SRNE) United States $0.271B 0.00
Axsome Therapeutics (AXSM) United States $0.262B 0.00
Liquidia Technologies (LQDA) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.258B 0.00
Merus (MRUS) Netherlands $0.254B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.252B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.251B 0.00
Synlogic (SYBX) United States $0.242B 0.00
Seres Therapeutics (MCRB) United States $0.241B 0.00
Celcuity (CELC) United States $0.240B 0.00
Kamada (KMDA) Israel $0.236B 10.64
MannKind (MNKD) United States $0.235B 0.00
Verastem (VSTM) United States $0.231B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.229B 0.00
Sutro Biopharma (STRO) United States $0.229B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.229B 0.00
ResTORbio (TORC) United States $0.225B 0.00
Adverum Biotechnologies (ADVM) United States $0.225B 0.00
Strongbridge Biopharma (SBBP) United States $0.218B 0.00
ChromaDex (CDXC) United States $0.215B 0.00
Cerecor (CERC) United States $0.211B 0.00
Athersys (ATHX) United States $0.210B 0.00
Celyad SA (CYAD) Belgium $0.209B 0.00
TOCAGEN INC (TOCA) United States $0.207B 0.00
Syros Pharmaceuticals (SYRS) United States $0.205B 0.00
Arbutus Biopharma (ABUS) Canada $0.202B 0.00
LogicBio Therapeutics (LOGC) United States $0.201B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.199B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.196B 0.00
CorMedix Inc (CRMD) United States $0.196B 0.00
Spero Therapeutics (SPRO) United States $0.193B 0.00
Aptinyx (APTX) United States $0.187B 0.00
ADMA Biologics Inc (ADMA) United States $0.185B 0.00
Axovant Sciences (AXGT) United Kingdom $0.184B 0.00
Compugen (CGEN) Israel $0.181B 0.00
Protagonist Therapeutics (PTGX) United States $0.173B 0.00
Menlo Therapeutics (MNLO) United States $0.171B 0.00
Enzo Biochem (ENZ) United States $0.167B 0.00
Palatin Technologies (PTN) United States $0.163B 80.19
Mersana Therapeutics (MRSN) United States $0.163B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.162B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.162B 0.00
VBI Vaccines (VBIV) United States $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.152B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.149B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.148B 0.00
Proteostasis Therapeutics (PTI) United States $0.148B 0.00
BioTime (BTX) United States $0.146B 0.00
OvaScience (MLND) United States $0.142B 0.00
Allena Pharmaceuticals (ALNA) United States $0.133B 0.00
BioXcel Therapeutics (BTAI) United States $0.129B 0.00
Eton Pharmaceuticals (ETON) United States $0.129B 0.00
Cohbar (CWBR) United States $0.129B 0.00
Cue Biopharma (CUE) United States $0.128B 0.00
Organovo Holdings (ONVO) United States $0.128B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.127B 0.00
Pfenex (PFNX) United States $0.124B 0.00
Unum Therapeutics (UMRX) United States $0.124B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.123B 0.00
Fortress Biotech (FBIO) United States $0.121B 0.00
XOMA (XOMA) United States $0.119B 0.00
Pluristem Therapeutics (PSTI) Israel $0.119B 0.00
Trevena (TRVN) United States $0.117B 0.00
Checkpoint Therapeutics (CKPT) United States $0.114B 0.00
Oncobiologics (OTLK) United States $0.112B 0.00
Mustang Bio (MBIO) United States $0.112B 0.00
Anavex Life Sciences (AVXL) United States $0.111B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.107B 0.00
Equillium (EQ) United States $0.105B 0.00
VolitionRX (VNRX) Singapore $0.103B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.102B 0.00
Chiasma (CHMA) United States $0.097B 0.00
VTv Therapeutics (VTVT) United States $0.094B 0.00
NantKwest (NK) United States $0.093B 0.00
Signal Genetics (MGEN) United States $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
Cel-Sci (CVM) United States $0.082B 0.00
Orgenesis (ORGS) United States $0.081B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 88.33
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.079B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.078B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.078B 0.00
Alimera Sciences (ALIM) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
Provention Bio (PRVB) United States $0.077B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.076B 0.00
PHASEBIO PHARMA (PHAS) United States $0.073B 0.00
Aptose Biosciences (APTO) Canada $0.072B 0.00
Idera Pharmaceuticals (IDRA) United States $0.072B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
NewLink Genetics (NLNK) United States $0.067B 0.00
Protalix BioTherapeutics (PLX) Israel $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.067B 12.66
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Celldex Therapeutics (CLDX) United States $0.065B 0.00
SESEN BIO, INC (SESN) United States $0.063B 0.00
Applied Genetic Technologies (AGTC) United States $0.061B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Prima BioMed (IMMP) Australia $0.058B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Eyenovia (EYEN) United States $0.057B 0.00
ARAVIVE, INC (ARAV) United States $0.057B 4.98
Proteon Therapeutics (PRTO) United States $0.056B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.056B 0.00
VIVUS (VVUS) United States $0.056B 0.00
Clearside Biomedical (CLSD) United States $0.056B 0.00
Ophthotech (OPHT) United States $0.055B 0.00
Vaccinex (VCNX) United States $0.055B 0.00
Alcobra (ARCT) United States $0.053B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.052B 0.00
Asterias Biotherapeutics (AST) United States $0.051B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Entera Bio (ENTX) Israel $0.051B 0.00
Bellerophon Therapeutics (BLPH) United States $0.046B 0.00
OVID THERAPEUTC (OVID) United States $0.046B 0.00
Selecta Biosciences (SELB) United States $0.045B 0.00
DiaMedica Therapeutics (DMAC) United States $0.043B 0.00
VistaGen Therapeutics (VTGN) United States $0.042B 0.00
Bionano Genomics (BNGO) United States $0.041B 0.00
Caladrius Biosciences (CLBS) United States $0.041B 0.00
Celsion (CLSN) United States $0.040B 0.00
OncoSec Medical (ONCS) United States $0.038B 0.00
Aptevo Therapeutics (APVO) United States $0.038B 0.00
Curis (CRIS) United States $0.037B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Arsanis (ASNS) United States $0.037B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
AZURRX BIOPHARM (AZRX) United States $0.034B 0.00
Leap Therapeutics (LPTX) United States $0.034B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.033B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.031B 5.08
Galena Biopharma (SLS) United States $0.031B 0.00
TRACON Pharmaceuticals (TCON) United States $0.029B 0.00
Motif Bio Plc (MTFB) United States $0.029B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.029B 0.00
IMMURON LTD (IMRN) Australia $0.028B 0.00
Oragenics (OGEN) United States $0.026B 0.00
Zosano Pharma (ZSAN) United States $0.026B 0.00
Aileron Therapeutics (ALRN) United States $0.026B 0.00
Advaxis (ADXS) United States $0.025B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Adial Pharmaceuticals (ADIL) United States $0.024B 0.00
Vical (VICL) United States $0.022B 0.00
BioPharmX (BPMX) United States $0.022B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.021B 0.00
GTx (GTXI) United States $0.021B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.021B 0.00
CytRx (CYTR) United States $0.020B 0.00
Apricus Biosciences (SEEL) United States $0.019B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Benitec Biopharma (BNTC) Australia $0.018B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
IBio (IBIO) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.63
ATyr Pharma (LIFE) United States $0.015B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Soligenix (SNGX) United States $0.015B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Aytu Bioscience (AYTU) United States $0.013B 0.00
Edge Therapeutics (EDGE) United States $0.012B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
TrovaGene (TROV) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.011B 0.00
MYOS RENS Technology (MYOS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.010B 0.00
Neuralstem (CUR) United States $0.009B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
RestorGenex (DFFN) United States $0.009B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Synthetic Biologics (SYN) United States $0.009B 0.00
Histogenics (HSGX) United States $0.008B 0.00
AmpliPhi Biosciences (APHB) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
Flex Pharma (FLKS) United States $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.002B 0.00